Literature DB >> 32271472

Coenzyme Q10 effect on semen parameters: Profound or meagre?

Rahul Vishvkarma1, Ahmed T Alahmar2, Gopal Gupta1, Singh Rajender1.   

Abstract

Coenzyme Q10 has shown promise in treating male infertility; however, there are inconsistencies across the published data. We undertook a quantitative meta-analysis by pooling data from three placebo-controlled randomised clinical trials (RCTs) in order to evaluate the efficacy of CoQ10 in improving semen parameters. Sperm count, sperm motility, sperm forward motility, sperm morphology and CoQ10 level in the seminal plasma were measured and quantitatively correlated with CoQ10 oral administration. Pooled analysis showed a significant impact of CoQ10 in improving sperm motility and forward motility, without a significant impact on sperm count, sperm morphology, ejaculate volume or seminal plasma level of CoQ10. Efficacy assessment suggested that CoQ10 shows better results at higher doses and when administered for a period of more than 3 months but not longer than 6 months. We conclude that CoQ10 has a profound effect on sperm motility and a meagre effect on all other parameters. Therefore, CoQ10 can be used for treating asthenozoospermic infertility with the dosage and duration depending upon the severity of the disorder and the patient's response to the treatment.
© 2020 Blackwell Verlag GmbH.

Entities:  

Keywords:  CoQ10; Coenzyme Q10; asthenozoospermia; male infertility; sperm motility

Mesh:

Substances:

Year:  2020        PMID: 32271472     DOI: 10.1111/and.13570

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  6 in total

Review 1.  Infertility in Men: Advances towards a Comprehensive and Integrative Strategy for Precision Theranostics.

Authors:  Mourad Assidi
Journal:  Cells       Date:  2022-05-22       Impact factor: 7.666

2.  The Effect of Antioxidants on Sperm Quality Parameters and Pregnancy Rates for Idiopathic Male Infertility: A Network Meta-Analysis of Randomized Controlled Trials.

Authors:  Kun-Peng Li; Xue-Song Yang; Tao Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-21       Impact factor: 5.555

3.  Comparison of the effects of coenzyme Q10 and Centrum multivitamins on semen parameters, oxidative stress markers, and sperm DNA fragmentation in infertile men with idiopathic oligoasthenospermia.

Authors:  Ahmed T Alahmar; Rajender Singh
Journal:  Clin Exp Reprod Med       Date:  2022-02-24

4.  Studies on improving semen quality and increasing pregnancy chances through the in vitro addition of L-carnitine and coenzyme Q10 to semen in patients with asthenozoospermia.

Authors:  Chengren Gou; Zidong Zhou; Zongping Chen; Kun Wang; Congcong Chen; Bo Chen; Ningrui Pan; Xu He
Journal:  Basic Clin Androl       Date:  2022-10-04

5.  Predictors of pregnancy and time to pregnancy in infertile men with idiopathic oligoasthenospermia pre- and post-coenzyme Q10 therapy.

Authors:  Ahmed T Alahmar; Roozbeh Naemi
Journal:  Andrologia       Date:  2022-02-01       Impact factor: 2.532

Review 6.  Dietary Antioxidants in the Treatment of Male Infertility: Counteracting Oxidative Stress.

Authors:  Elizabeth Torres-Arce; Barbara Vizmanos; Nancy Babio; Fabiola Márquez-Sandoval; Albert Salas-Huetos
Journal:  Biology (Basel)       Date:  2021-03-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.